vs
Side-by-side financial comparison of National Storage Affiliates Trust (NSA) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
National Storage Affiliates Trust is the larger business by last-quarter revenue ($187.0M vs $158.6M, roughly 1.2× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 12.2%, a 58.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -1.6%). National Storage Affiliates Trust produced more free cash flow last quarter ($299.8M vs $131.7M).
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
NSA vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $187.0M | $158.6M |
| Net Profit | $22.9M | $112.9M |
| Gross Margin | 72.5% | — |
| Operating Margin | 20.2% | 70.2% |
| Net Margin | 12.2% | 71.2% |
| Revenue YoY | -1.6% | 3661.1% |
| Net Profit YoY | 36.8% | 528.0% |
| EPS (diluted) | $0.23 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $187.0M | — | ||
| Q3 25 | $188.7M | — | ||
| Q2 25 | $188.8M | — | ||
| Q1 25 | $188.4M | $158.6M | ||
| Q4 24 | $190.1M | $22.6M | ||
| Q3 24 | $193.6M | — | ||
| Q2 24 | $190.4M | — | ||
| Q1 24 | $196.1M | — |
| Q4 25 | $22.9M | — | ||
| Q3 25 | $18.4M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $13.0M | $112.9M | ||
| Q4 24 | $16.7M | $-10.5M | ||
| Q3 24 | $18.7M | — | ||
| Q2 24 | $17.1M | — | ||
| Q1 24 | $59.0M | — |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 70.7% | — | ||
| Q2 25 | 70.5% | — | ||
| Q1 25 | 70.7% | — | ||
| Q4 24 | 72.5% | — | ||
| Q3 24 | 72.8% | — | ||
| Q2 24 | 72.6% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | 20.2% | — | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 11.0% | 70.2% | ||
| Q4 24 | 14.5% | -60.4% | ||
| Q3 24 | 15.8% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 48.9% | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 6.9% | 71.2% | ||
| Q4 24 | 8.8% | -46.4% | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | 30.1% | — |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.17 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.10 | $1.90 | ||
| Q4 24 | $0.19 | $-0.15 | ||
| Q3 24 | $0.18 | — | ||
| Q2 24 | $0.16 | — | ||
| Q1 24 | $0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $946.0M | $350.1M |
| Total Assets | $5.1B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.3M | — | ||
| Q3 25 | $26.3M | — | ||
| Q2 25 | $26.1M | — | ||
| Q1 25 | $19.3M | $274.8M | ||
| Q4 24 | $50.4M | $128.0M | ||
| Q3 24 | $69.9M | — | ||
| Q2 24 | $59.0M | — | ||
| Q1 24 | $64.2M | — |
| Q4 25 | $946.0M | — | ||
| Q3 25 | $973.1M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.0B | $350.1M | ||
| Q4 24 | $1.1B | $229.0M | ||
| Q3 24 | $986.9M | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.3B | — |
| Q4 25 | $5.1B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.3B | $406.9M | ||
| Q4 24 | $5.4B | $271.6M | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.3B | — | ||
| Q1 24 | $5.4B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $338.5M | $131.8M |
| Free Cash FlowOCF − Capex | $299.8M | $131.7M |
| FCF MarginFCF / Revenue | 160.3% | 83.0% |
| Capex IntensityCapex / Revenue | 20.7% | 0.1% |
| Cash ConversionOCF / Net Profit | 14.79× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $541.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $338.5M | — | ||
| Q3 25 | $100.2M | — | ||
| Q2 25 | $79.9M | — | ||
| Q1 25 | $85.6M | $131.8M | ||
| Q4 24 | $363.1M | $-23.2M | ||
| Q3 24 | $105.7M | — | ||
| Q2 24 | $83.2M | — | ||
| Q1 24 | $94.0M | — |
| Q4 25 | $299.8M | — | ||
| Q3 25 | $88.0M | — | ||
| Q2 25 | $73.8M | — | ||
| Q1 25 | $79.9M | $131.7M | ||
| Q4 24 | $344.4M | $-23.2M | ||
| Q3 24 | $101.8M | — | ||
| Q2 24 | $79.5M | — | ||
| Q1 24 | $88.6M | — |
| Q4 25 | 160.3% | — | ||
| Q3 25 | 46.6% | — | ||
| Q2 25 | 39.1% | — | ||
| Q1 25 | 42.4% | 83.0% | ||
| Q4 24 | 181.2% | -102.7% | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | 41.7% | — | ||
| Q1 24 | 45.2% | — |
| Q4 25 | 20.7% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 9.8% | 0.2% | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | 14.79× | — | ||
| Q3 25 | 5.44× | — | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 6.59× | 1.17× | ||
| Q4 24 | 21.70× | — | ||
| Q3 24 | 5.65× | — | ||
| Q2 24 | 4.88× | — | ||
| Q1 24 | 1.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
